During the past decade, Affiliated Hospital of Chengdu University conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated Hospital of Chengdu University" #1 collaborator was "Peking University" with 1 trials as a collaborator and "Shanghai Greenvalley Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Affiliated Hospital of Chengdu University" are "Advanced Hepatocellular Carcinoma (HCC)" (1 trials) and "Adverse Drug Reaction" (1 trials). Many other conditions were trialed in "Affiliated Hospital of Chengdu University" in a lesser frequency.

Most popular intervention types in "Affiliated Hospital of Chengdu University" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AK105 Injection" (1 trials), "Anlotinib Hydrochloride Capsules" (1 trials) and "Sorafenib Tosylate Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated Hospital of Chengdu University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Affiliated Hospital of Chengdu University". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Affiliated Hospital of Chengdu University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated Hospital of Chengdu University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".